Health ❯Healthcare ❯Public Health ❯Disease Management

Alzheimer's Disease

EMA Approves Lecanemab for Early-Stage Alzheimer’s Treatment in EU

EU Regulator Denies Approval for Alzheimer's Drug Lecanemab